Related Experiment Videos
Thrombocytopenia and low-dose heparin
Southern Medical Journal
|April 1, 1983
Summary
Low-dose heparin can cause thrombocytopenia, a dangerous drop in platelet count. Early detection is crucial for patient safety, especially with widespread heparin use for prophylaxis.
Area of Science:
- Hematology
- Pharmacology
Background:
- Low-dose heparin is frequently used for preventing thromboembolism.
- Heparin-associated thrombocytopenia (HAT) is a known complication.
Observation:
- Two cases of thrombocytopenia during low-dose heparin therapy were observed.
- These cases align with the described spectrum of heparin-associated thrombocytopenia.
Findings:
- Thrombocytopenia can occur even with low-dose heparin administration.
- A modest decrease in platelet count warrants investigation for heparin association.
Implications:
- Increased vigilance for thrombocytopenia is necessary in patients receiving low-dose heparin.
- Awareness of this adverse effect is critical due to potential reexposure risks.